Sector Gamma AS
- SEC CIK
- 0001475373
- Latest filing
- Aug 12, 2026
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 5, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 37
- −3 vs. Q1 2022
- Portfolio value
- $447.0M
- −$13.3M (−2.9%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| GILDGilead Sciences, Inc. | Stock | 843,427 | $52.1M | 11.7% | +161,889+23.8% | Added | History |
| MRKMerck & Co., Inc. | Stock | 414,338 | $37.8M | 8.5% | −84,803−17.0% | Reduced | History |
| INCYIncyte Corp | COM | 459,429 | $34.9M | 7.8% | +17,417+3.9% | Added | History |
| MDTMedtronic plc | Stock | 290,521 | $26.1M | 5.8% | +84,515+41.0% | Added | History |
| BMYBristol Myers Squibb Co | Stock | 311,696 | $24.0M | 5.4% | −21,862−6.6% | Reduced | History |
| CAHCardinal Health Inc | Stock | 385,988 | $20.2M | 4.5% | +8,718+2.3% | Added | History |
| BSXBoston Scientific Corp | Stock | 532,735 | $19.9M | 4.4% | +137,400+34.8% | Added | History |
| BIIBBiogen Inc. | COM | 92,497 | $18.9M | 4.2% | +10,552+12.9% | Added | History |
| CICigna Group | Stock | 66,283 | $17.5M | 3.9% | +7,913+13.6% | Added | History |
| ELVElevance Health, Inc. | Stock | 34,300 | $16.6M | 3.7% | +5,282+18.2% | Added | History |
| BRKRBruker Corp | COM | 251,042 | $15.8M | 3.5% | −910−0.4% | Reduced | History |
| CVSCVS Health Corp | Stock | 168,111 | $15.6M | 3.5% | −30,762−15.5% | Reduced | History |
| CNCCentene Corp | Stock | 181,799 | $15.4M | 3.4% | −12,865−6.6% | Reduced | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 135,749 | $14.3M | 3.2% | +70,948+109.5% | Added | History |
| NUVANuvasive Inc | COM | 247,502 | $12.2M | 2.7% | −18,533−7.0% | Reduced | History |
| OGNOrganon & Co. | Stock | 356,089 | $12.0M | 2.7% | +16,351+4.8% | Added | History |
| QGENQiagen N.V. | SHS NEW | 201,729 | $9.52M | 2.1% | −17,497−8.0% | Reduced | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 33,474 | $9.43M | 2.1% | +8,716+35.2% | Added | History |
| SGENSeagen Inc. | COM | 50,795 | $8.99M | 2.0% | +50,795 | New | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 105,259 | $8.72M | 2.0% | +25,500+32.0% | Added | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 42,844 | $6.25M | 1.4% | −16,407−27.7% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 165,439 | $6.13M | 1.4% | −23,000−12.2% | Reduced | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 11,785 | $5.83M | 1.3% | −1,000−7.8% | Reduced | History |
| ABTAbbott Laboratories | Stock | 49,205 | $5.35M | 1.2% | +49,205 | New | History |
| PFEPfizer Inc | Stock | 100,000 | $5.24M | 1.2% | −29,738−22.9% | Reduced | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 80,843 | $4.62M | 1.0% | 00.0% | Unchanged | History |
| SAGESage Therapeutics, Inc. | COM | 118,476 | $3.83M | 0.9% | 00.0% | Unchanged | History |
| PTCTPTC Therapeutics, Inc. | COM | 84,864 | $3.40M | 0.8% | +5,000+6.3% | Added | History |
| NVAXNovavax Inc | COM NEW | 55,324 | $2.85M | 0.6% | +17,000+44.4% | Added | History |
| VIRVir Biotechnology, Inc. | COM | 110,223 | $2.81M | 0.6% | +30,000+37.4% | Added | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 46,221 | $2.76M | 0.6% | 00.0% | Unchanged | History |
| UHSUniversal Health Services Inc | CL B | 27,077 | $2.73M | 0.6% | −20,390−43.0% | Reduced | History |
| RIGLRigel Pharmaceuticals Inc | COM NEW | 1,466,678 | $1.66M | 0.4% | 00.0% | Unchanged | History |
| QTRXQuanterix Corp | COM | 88,670 | $1.44M | 0.3% | 00.0% | Unchanged | History |
| SLGCSomaLogic, Inc. | CLASS A COM | 301,224 | $1.36M | 0.3% | 00.0% | Unchanged | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 123,713 | $964.0K | 0.2% | 00.0% | Unchanged | History |
| EMBCEmbecta Corp. | Stock | 5,246 | $133.0K | <0.1% | +5,246 | New | History |
Sold out since Q1 2022 (6)
Positions held at the end of Q1 2022 that are gone from this filing.
| Security | Class | Shares in Q1 2022 | Value in Q1 2022 | % of portfolio in Q1 2022 | History |
|---|---|---|---|---|---|
| ELANElanco Animal Health Inc | COM | 364,691 | $9.52M | 2.1% | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 124,000 | $8.23M | 1.8% | History |
| BDXBecton Dickinson & Co | Stock | 26,233 | $6.98M | 1.5% | History |
| PDCOPatterson Companies, Inc. | COM | 129,757 | $4.20M | 0.9% | History |
| XRAYDentsply Sirona Inc. | Stock | 55,516 | $2.73M | 0.6% | History |
| MRTXMirati Therapeutics, Inc. | COM | 11,875 | $976.0K | 0.2% | History |